Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 38
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02406287 | A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers | ||
| NCT03808688 | Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting | ||
| NCT01699464 | A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months | ||
| NCT05360966 | Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3) | ||
| NCT01997879 | Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers | ||
| NCT02057575 | Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure | ||
| NCT01789736 | A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days | ||
| NCT01060579 | Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure | ||
| NCT03739593 | Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) | ||
| NCT02207491 | Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension | ||
| NCT02207621 | Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension | ||
| NCT02246764 | Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension | ||
| NCT01731002 | Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure | ||
| NCT03310580 | Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension | ||
| NCT02558400 | Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension | ||
| NCT04064918 | Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity | ||
| NCT01250197 | Formulation Comparison in Normal Volunteers | ||
| NCT05497479 | Study Evaluating Techniques for Measuring Tear Production | ||
| NCT04498169 | A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy | ||
| NCT04498182 | A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease | ||
| NCT03835884 | A Study Assessing AR-13503 Implant in Subjects With nAMD or DME | ||
| NCT04620135 | Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension | ||
| NCT01330979 | 24-hour Efficacy of AR-12286 | ||
| NCT02674854 | Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension | ||
| NCT05283395 | Rocklatan® Evaluation | ||
| NCT02874846 | Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution | ||
| NCT05493111 | A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512 | ||
| NCT01302249 | AR-12286 in Combination With Latanoprost | ||
| NCT01528787 | Study of AR-13324 in Patients With Elevated Intraocular Pressure | ||
| NCT03844945 | Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan | ||
| NCT04401982 | Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects | ||
| NCT01474135 | AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure | ||
| NCT00523250 | Ocular Hypotensive Efficacy of AR-102 | ||
| NCT05285644 | Study Evaluating the Safety and Efficacy of AR-15512 | ||
| NCT03284853 | Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension | ||
| NCT02558374 | Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension | ||
| NCT03233308 | Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) | ||
| NCT00902200 | A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) |
